Red Cedar Investment Management’s AbbVie ABBV Stock Holding History

Red Cedar Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.81M	Hold	27,046	–	–	0.64%	35
2026 Q1	$5.88M	Sell	27,046 -164	-0.6%	-$36.4K	0.61%	34
2025 Q4	$6.22M	Hold	27,210	–	–	0.67%	29
2025 Q3	$6.3M	Hold	27,210	–	–	0.74%	26
2025 Q2	$5.05M	Hold	27,210	–	–	0.64%	28
2025 Q1	$5.7M	Hold	27,210	–	–	0.79%	19
2024 Q4	$4.84M	Sell	27,210 -8,717	-24%	-$1.6M	0.61%	23
2024 Q3	$7.09M	Hold	35,927	–	–	0.9%	17
2024 Q2	$6.16M	Hold	35,927	–	–	0.84%	18
2024 Q1	$6.54M	Buy	35,927 +3,035	+9%	+$523K	0.82%	19
2023 Q4	$5.1M	Hold	32,892	–	–	0.73%	22
2023 Q3	$4.9M	Buy	32,892 +308	+0.9%	+$45.2K	0.75%	18
2023 Q2	$4.39M	Hold	32,584	–	–	0.67%	22
2023 Q1	$5.19M	Buy	32,584 +10,517	+48%	+$1.61M	0.8%	16
2022 Q4	$3.57M	Buy	22,067 +1,555	+8%	+$238K	0.56%	24
2022 Q3	$2.75M	Buy	20,512 +2,186	+12%	+$314K	0.47%	27
2022 Q2	$2.81M	Sell	18,326 -4,114	-18%	-$629K	0.46%	27
2022 Q1	$3.64M	Buy	22,440 +2,955	+15%	+$429K	0.51%	26
2021 Q4	$2.64M	Hold	19,485	–	–	0.32%	35
2021 Q3	$2.1M	Buy	19,485 +3,273	+20%	+$374K	0.27%	31
2021 Q2	$1.83M	Sell	16,212 -3,273	-17%	-$369K	0.24%	37
2021 Q1	$2.11M	Hold	19,485	–	–	0.27%	34
2020 Q4	$2.09M	Buy	19,485 +16,399	+531%	+$1.58M	0.31%	31
2020 Q3	$270K	Buy	+3,086	New	+$291K	0.05%	71

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Red Cedar Investment Management's ABBV Position: Q2 2026 in Review

Red Cedar Investment Management held its AbbVie (ABBV) position steady in Q2 2026 at 27,046 shares worth $6.81M. The position accounts for 0.64% of the portfolio, ranked #35.

Red Cedar Investment Management first reported a position in ABBV in Q3 2020 and has held it in 24 quarters since. The position peaked at $7.09M in Q3 2024. 4,227 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Red Cedar Investment Management held 27,046 shares of AbbVie worth $6.81M as of Q2 2026.
Red Cedar Investment Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.64% of Red Cedar Investment Management's portfolio in Q2 2026, its #35 holding.
Red Cedar Investment Management first reported a position in AbbVie in Q3 2020 and has held it in 24 quarters since.
Red Cedar Investment Management's AbbVie position peaked at $7.09M in Q3 2024.
4,227 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Red Cedar Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.